Who We Are
What We Do
P-MAPP: Personalized Medication Adherence and Persistence Program
Launched in September 2019
Focuses on Patients with Type 2 Diabetes
Closing the prescription accountability loop among pharma, pharmacies, prescribers, payers and patients with Type 2 Diabetes
Want to learn more about the P-MAPP?
Visit P-MAPP Website